Cargando…
Proteomes from AMPK-inhibited peripheral blood mononuclear cells suppress the progression of breast cancer and bone metastasis
Background: During a developmental process, embryos employ varying tactics to remove unwanted cells. Using a procedure analogous to some of the embryonic cells, we generated a tumor-eliminating conditioned medium (CM) from AMPK-inhibited lymphocytes and monocytes in peripheral blood mononuclear cell...
Autores principales: | Li, Kexin, Sun, Xun, Minami, Kazumasa, Tamari, Keisuke, Ogawa, Kazuhiko, Li, Hudie, Ma, Hailan, Zhou, Meng, Na, Sungsoo, Li, Bai-Yan, Yokota, Hiroki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008730/ https://www.ncbi.nlm.nih.gov/pubmed/36923539 http://dx.doi.org/10.7150/thno.80294 |
Ejemplares similares
-
Suppression of osteosarcoma progression by engineered lymphocyte-derived proteomes
por: Li, Kexin, et al.
Publicado: (2022) -
Exploring the Tumor-Suppressing Potential of PSCA in Pancreatic Ductal Adenocarcinoma
por: Li, Kexin, et al.
Publicado: (2023) -
The inhibition of pancreatic cancer progression by K-Ras-overexpressing mesenchymal stem cell-derived secretomes
por: Huo, Qingji, et al.
Publicado: (2023) -
PI3K-activated MSC proteomes inhibit mammary tumors via Hsp90ab1 and Myh9
por: Sun, Xun, et al.
Publicado: (2022) -
Carbon ion irradiation enhances the antitumor efficacy of dual immune checkpoint blockade therapy both for local and distant sites in murine osteosarcoma
por: Takahashi, Yutaka, et al.
Publicado: (2019)